Department of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Md.
Department of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, Md; Environmental Health and Engineering, Johns Hopkins Bloomberg School of Public Health, Baltimore, Md.
J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1815-1822.e2. doi: 10.1016/j.jaip.2019.01.051. Epub 2019 Feb 11.
Indoor fine particulate air pollution (PM) is linked to asthma morbidity; however, whether vitamin D status influences individual susceptibility to airborne exposures is unclear.
We aimed to determine if vitamin D modifies the effects of indoor PM on asthma symptoms in urban children.
A total of 120 children aged 5 to 12 years with physician-diagnosed asthma were evaluated at baseline and every 3 months for 9 months. Indoor PM, serum 25-hydroxy vitamin D (25-OH D) levels, and asthma symptoms were simultaneously assessed at each time point. Adjusting for confounders, generalized estimating equations assessed the 3-way interaction effects of 25-OH D, obesity, and PM on asthma symptoms.
Children were of mean (standard deviation [SD]) age 9.7 (2.2) years, 36% were obese, and 95% self-reported black race. Mean (SD) PM indoor exposure was 38.2 (42.9) μg/m and 25-OH D was 19.1 (7.5) ng/mL. Three-way interaction models demonstrated significantly greater PM-associated effects on daytime asthma symptoms only among obese children with low 25-OH D levels (odds ratio [OR] = 1.26, P = .049 at vitamin D = 15.5 ng/mL, increasingly stronger PM effects at levels <15.5 ng/mL). In homes with increased PM, higher 25-OH D was associated with decreased symptom odds (eg, OR = 0.87; P = .049 at PM = 52.5 μg/m, increasingly protective effects >52.5 μg/m) among obese children.
Among obese urban children with asthma, low individual 25-OH D enhanced adverse respiratory effects associated with indoor PM. In high PM environments, 25-OH D was protective against asthma symptoms. Optimizing vitamin D status in children may help reduce asthma morbidity driven by indoor air pollution.
室内细颗粒物空气污染(PM)与哮喘发病率有关;然而,维生素 D 状况是否会影响个体对空气传播暴露的敏感性尚不清楚。
我们旨在确定维生素 D 是否会改变室内 PM 对城市儿童哮喘症状的影响。
共有 120 名 5 至 12 岁的经医生诊断患有哮喘的儿童在基线和 9 个月内每 3 个月接受一次评估。在每个时间点同时评估室内 PM、血清 25-羟维生素 D(25-OH D)水平和哮喘症状。调整混杂因素后,使用广义估计方程评估 25-OH D、肥胖和 PM 对哮喘症状的三向交互作用。
儿童的平均(标准差[SD])年龄为 9.7(2.2)岁,36%为肥胖,95%自我报告为黑人。室内 PM 暴露的平均(SD)为 38.2(42.9)μg/m,25-OH D 为 19.1(7.5)ng/mL。三向交互模型显示,仅在低 25-OH D 水平的肥胖儿童中,PM 与日间哮喘症状的关联具有更大的影响(比值比[OR]为 1.26,P=0.049,在维生素 D=15.5ng/mL 时,在水平<15.5ng/mL 时,PM 影响逐渐增强)。在 PM 增加的家庭中,较高的 25-OH D 与症状几率降低相关(例如,在 PM=52.5μg/m 时,OR=0.87,P=0.049,在 PM>52.5μg/m 时,保护作用逐渐增强)在肥胖儿童中。
在肥胖的哮喘儿童中,个体 25-OH D 水平较低会增强与室内 PM 相关的不良呼吸影响。在高 PM 环境中,25-OH D 可预防哮喘症状。优化儿童的维生素 D 状况可能有助于减少室内空气污染引起的哮喘发病率。